JPS6468324A - Pharmacological medicine of cyclophosphamide or phosphamide - Google Patents

Pharmacological medicine of cyclophosphamide or phosphamide

Info

Publication number
JPS6468324A
JPS6468324A JP21930687A JP21930687A JPS6468324A JP S6468324 A JPS6468324 A JP S6468324A JP 21930687 A JP21930687 A JP 21930687A JP 21930687 A JP21930687 A JP 21930687A JP S6468324 A JPS6468324 A JP S6468324A
Authority
JP
Japan
Prior art keywords
cyclophosphamide
ifosfamide
container
solution
volume
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP21930687A
Other languages
Japanese (ja)
Inventor
Zauerubiiru Deiitaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma AG filed Critical Asta Pharma AG
Priority to JP21930687A priority Critical patent/JPS6468324A/en
Publication of JPS6468324A publication Critical patent/JPS6468324A/en
Pending legal-status Critical Current

Links

Landscapes

  • Filling Of Jars Or Cans And Processes For Cleaning And Sealing Jars (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: To obtain a pharmaceutical cytostatic agent preparation containing cyclophosphamide or ifosfamide in a closable container having a specific volume and enabling to achieve the rapid and perfect dissolution of the ingredients. CONSTITUTION: This pharmaceutical preparation contains cyclophosphamide or ifosfamide in a closable container. The volume of the container is 5-40ml, advantageously 6-20ml, for 100mg of the cyclophosphamide (anhydrous), and 2-40ml, advantageously 4-6ml, for 100mg of the ifosfamide. Therein, 100mg of the cyclophosphamide gives 2.5-20ml of the solution, and 100gm of the ifosfamide also gives 1-20ml of the solution. The method can perfectly be performed by dissolving the unit dose with a larger container in a larger volume than those of a convention al one, when the preparation of the cyclophosphamide or the ifosfamide as a cytostatic agent is prepared as an injection solution just before used.
JP21930687A 1987-09-03 1987-09-03 Pharmacological medicine of cyclophosphamide or phosphamide Pending JPS6468324A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21930687A JPS6468324A (en) 1987-09-03 1987-09-03 Pharmacological medicine of cyclophosphamide or phosphamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21930687A JPS6468324A (en) 1987-09-03 1987-09-03 Pharmacological medicine of cyclophosphamide or phosphamide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP7984593A Division JPH06100452A (en) 1993-04-06 1993-04-06 Pharmaceutical container for iphosphamide

Publications (1)

Publication Number Publication Date
JPS6468324A true JPS6468324A (en) 1989-03-14

Family

ID=16733424

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21930687A Pending JPS6468324A (en) 1987-09-03 1987-09-03 Pharmacological medicine of cyclophosphamide or phosphamide

Country Status (1)

Country Link
JP (1) JPS6468324A (en)

Similar Documents

Publication Publication Date Title
HUT34349A (en) Process for producing galenic pharmaceutical compositions
PT78191B (en) Process for preparing novel salts of omeprazole and of pharmaceutical compositions containing the same
MY100795A (en) Orally administrable antidiabetic compositions.
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
EP0137542A3 (en) Pharmaceutical composition for the treatment of states of acute renal insufficiency
JPS6463522A (en) Pharmaceutical composition for treating and preventing gallstone and gall deficient indigestion
BR9909637A (en) Process for the production of a tablet of compacted particulate composition, tablet of compacted particulate composition, and, uses of crystals or hydrated or anhydrous sodium acetate, potassium acetate or mixtures thereof and crystals or hydrated sodium acetate trihydrate or anhydrous, potassium acetate or mixture thereof
IL97795A0 (en) Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles,their preparation and pharmaceutical compositions containing them
JPS6468324A (en) Pharmacological medicine of cyclophosphamide or phosphamide
ES475643A1 (en) Substituted pyrrolidines, process for their preparation and medicaments containing them.
US4590214A (en) Method of treatment for herpes
IE35419L (en) Pharmaceutical composition containing cyclobenzaprine
PT72026A (en) Process to prepare pharmaceutical compositions pharmaceutical compositions
GB2120529A (en) Methods of preparing and using intravenous nutrient compositions
JPS646214A (en) Remedy for ulcerative colonopathy
ZA807789B (en) Piperidine derivatives,their preparation,and pharmaceutical formulations containing these compounds
GB1117200A (en) A process for the manufacture of benzdiaz[1,4]epines
MY102923A (en) In-vial deposition of 7-(dihmethylaminoethylene) amino-9(alpha)-methoxymitosane
SU1608870A1 (en) Method of treatment of maxilla cystic neoplasmas
JPS5278819A (en) Isolation of glutaric acid from composition containing glutaric acid, succinic acid and adipic acid
GB2213062A (en) Pharmaceutical preparation having oestrogen action
JPS5470430A (en) Remedy for bradyacusia and tinnitus
JPS51123834A (en) A medicine against the headache
JPS5793908A (en) Bag containing glucose and electrolytic additive for administration through vein
EP0667153A4 (en) Method of manufacturing composition for solid medicine.